Transparency vs. Explainability: Practicalities, Benefits, and Issues

TBA

Moderator

• Matt Schmucki, Associate Director of Automation Engineering, Vertex Pharmaceuticals

Speaker

• Hussein Ezzeldin, Senior Staff Fellow, Center for Biologics Evaluation and Research (CBER), FDA (Invited)
• Tala Fakhouri, Associate Director for Policy, Center for Drug Evaluation and Research (CDER), FDA (Invited)
• Shawn Forrest, Biomedical Engineer, Center for Devices and Radiological Health (CDRH), FDA (Invited)
• Mike Salem, Associate Director Data Science at Gilead Sciences